Active Ingredient(s): Lifitegrast
FDA Approved: * July 11, 2016
Pharm Company: * SHIRE DEV LLC
Category: Vision / Eye Health

Lifitegrast, sold under the brand name Xiidra (/zadr/[1]), is a medication for the treatment of signs and symptoms of dry eye, a syndrome called keratoconjunctivitis sicca. Lifitegrast reduces inflammation by inhibiting inflammatory cell binding.[2] It is often used in conjunction with ciclosporin (Ikervis or Restasis) for dry eye treatment including meibomian gland dysfunction and inflammatory dry eye. Contents 1 Adverse effects 2 Pharmacology 2.1 Mechanism... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Xiidra 50 mg/ml Ophthalmic Solution/ Drops
NDC: 0078-0911
Novartis Pharmaceuticals Corporation
Xiidra 50 mg/ml Ophthalmic Solution/ Drops
NDC: 24208-911
Bausch & Lomb Incorporated
Xiidra 50 mg/ml Ophthalmic Solution/ Drops
NDC: 54092-606
Shire Us Manufacturing Inc.

Popular Topics

Any side effects from Xiidra?

Has anyone had experience with Xiidra, for dry eyes? I am curious if there are any side effects not listed by the compan...